2.13 (-%)
As of Oct 30, 2024
Source:
Esperion is a pharmaceutical company singularly focused on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol, or LDL-C. Through commercial execution and completion of our CLEAR Outcomes trial as well as advancing our pre-clinical pipeline, we continue to evolve into a differentiated, global cardiometabolic biotech.
Country | United States |
Headquarters | ann arbor, michigan |
Phone Number | 734-887-3903 |
Industry | manufacturing |
CEO | Sheldon L. Koenig |
Website | www.linkedin.com |